Adiponectin promotes endothelial progenitor cell number and function

FEBS Letters

Volumn 582, Issue 11, 2008, Pages 1607-1612

  Shibata, Rei ^a,b   Skurk, Carsten ^b   Ouchi, Noriyuki ^b   Galasso, Gennaro ^b   Kondo, Kazuhisa ^a   Ohashi, Taiki ^a   Shimano, Masayuki ^a   Kihara, Shinji ^c   Murohara, Toyoaki ^a   Walsh, Kenneth ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Adiponectin; Angiogenesis; Endothelial progenitor cell

Indexed keywords

ADENOVIRUS VECTOR; ADIPONECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; GENETIC MANIPULATION; HUMAN; HUMAN CELL; ISCHEMIA; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; WILD TYPE;

ADENOVIRIDAE; ADIPONECTIN; ANIMALS; CELL COUNT; CELL DIFFERENTIATION; CELL MOVEMENT; ENDOTHELIAL CELLS; HUMANS; MICE; MICE, KNOCKOUT; STEM CELLS; TRANSFECTION;

ADENOVIRIDAE; MUS;

EID: 42749088830     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.04.006     Document Type: Article

References (24)

1. Asahara T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., Levine J.P., and Gurtner G.C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786
3. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl. J. Med. 348 (2003) 593-600
4. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89 (2001) E1-E7
5. Gallagher K.A., et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J. Clin. Invest. 117 (2007) 1249-1259
6. Fadini G.P., Sartore S., Schiavon M., Albiero M., Baesso I., Cabrelle A., Agostini C., and Avogaro A. Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 49 (2006) 3075-3084
7. Hopkins T., Ouchi N., Shibata R., and Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc. Res. 74 (2007) 11-18
8. Shibata R., et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J. Mol. Cell Cardiol. 42 (2007) 1065-1074
9. Shibata R., Ouchi N., Kihara S., Sato K., Funahashi T., and Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J. Biol. Chem. 279 (2004) 28670-28674
10. Ouchi N., Kobayashi H., Kihara S., Kumada M., Sato K., Inoue T., Funahashi T., and Walsh K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 279 (2004) 1304-1309
11. Matsuda M., et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 277 (2002) 37487-37491
12. Maeda N., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8 (2002) 731-737
13. Hur J., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 288-293
14. Shimada T., et al. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 110 (2004) 1148-1155
15. Galasso G., et al. Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ. Res. 98 (2006) 254-261
16. Rocnik E.F., Liu P., Sato K., Walsh K., and Vaziri C. The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. J. Biol. Chem. 281 (2006) 22855-22864
17. Yoder M.C., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809
18. Matsuo Y., Imanishi T., Kuroi A., Kitabata H., Kubo T., Hayashi Y., Tomobuchi Y., and Akasaka T. Effects of plasma adiponectin levels on the number and function of endothelial progenitor cells in patients with coronary artery disease. Circ. J. 71 (2007) 1376-1382
19. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9 (2003) 702-712
20. Chen H., Montagnani M., Funahashi T., Shimomura I., and Quon M.J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 278 (2003) 45021-45026
21. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ihling K., Zeiher A.M., and Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9 (2003) 1370-1376
22. Werner C., Kamani C.H., Gensch C., Bohm M., and Laufs U. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 56 (2007) 2609-2615
23. Wang C.H., et al. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am. Heart J. 152 (2006) 1051 e1-8
24. Semple R.K., Chatterjee V.K., and O'Rahilly S. PPAR gamma and human metabolic disease. J. Clin. Invest. 116 (2006) 581-589